share_log

Merit Medical Anticipates Cook Medical Deal To Be Modestly Dilutive To Full-year 2024 Non-GAAP Profitability Given Partial-year Contribution

Merit Medical Anticipates Cook Medical Deal To Be Modestly Dilutive To Full-year 2024 Non-GAAP Profitability Given Partial-year Contribution

美敦力醫療預計,庫克醫療公司的交易將對2024全年非通用會計原則盈利產生適度的稀釋,考慮到部分年度貢獻。
Benzinga ·  09/17 07:08

Lampropoulos continued: "We have updated our full-year 2024 financial guidance to include the projected impact of this acquisition from a prospective closing date of October 31, 2024 to December 31, 2024 and, importantly, we have reaffirmed our updated full-year 2024 financial guidance previously issued on August 1, 2024."

Lampropoulos繼續說:"我們已經更新了2024年全年財務指導,並將預計的此次收購的影響從2024年10月31日到2024年12月31日,並且重申了之前於2024年8月1日發佈的更新後的2024年全年財務指導。"

"We look forward to discussing this acquisition and our updated outlook for 2024 on our third quarter earnings report on October 30, 2024."

"我們期待在2024年10月30日的第三季度收益報告中討論這次收購和我們更新的2024年展望。"

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論